Dysregulation of interleukin 8, interleukin 10, and interleukin 12 release by alveolar macrophages from HIV type 1-infected subjects.

We examined the in vitro release of interleukin 8 (IL-8), interleukin 10 (IL-10), and interleukin 12 (IL-12) by alveolar macrophages from normal volunteers and HIV-1-infected subjects. Normal volunteers had very low levels of IL-8 and IL-10 and undetectable IL-12 in the cell-free bronchoalveolar lavage fluid (BALF). Asymptomatic HIV-1-infected subjects had elevated levels of IL-8 and IL-10 in their BALF, and HIV-1-infected subjects with nonspecific interstitial pneumonitis (NIP) or infected with Pneumocystis carinii had the highest BALF levels of IL-10 and IL-8. It was found that alveolar macrophages from asymptomatic HIV-1 subjects and from NIP subjects spontaneously released elevated IL-8, IL-10, and IL-12. However, AIDS subjects infected with P. carinii had cells that released elevated levels of IL-10 and IL-8, but low levels of IL-12. When alveolar macrophages were stimulated with Staphylococcus aureus Cowan (SAC), cells from normal volunteers responded with a considerably increased release of IL-8, IL-10, and IL-12; cells from HIV-1-infected subjects without P. carinii infection responded with a moderate increase in release of all three monokines. SAC stimulation did not enhance the release of monokines by cells from AIDS subjects with P. carinii infection, and IL-12 levels remained low. There was no strict relationship between spontaneous cytokine release and p24 HIV-1 antigen expression by alveolar macrophages. Finally, we showed that neutralizing IL-10 production by alveolar macrophages from AIDS subjects substantially increased IL-12 releasability.(ABSTRACT TRUNCATED AT 250 WORDS)

[1]  S. Garbisa,et al.  Spontaneous production of interleukin-6 by alveolar macrophages from human immunodeficiency virus type 1-infected patients. , 1992, The Journal of infectious diseases.

[2]  A. Huber,et al.  Regulation of transendothelial neutrophil migration by endogenous interleukin-8. , 1991, Science.

[3]  C. Wanidworanun,et al.  Predominant role of tumor necrosis factor-alpha in human monocyte IL-10 synthesis. , 1993, Journal of immunology.

[4]  M. Denis,et al.  IL-10 neutralization augments mouse resistance to systemic Mycobacterium avium infections. , 1993, Journal of immunology.

[5]  A. Sher,et al.  IL-10 synergizes with IL-4 and transforming growth factor-beta to inhibit macrophage cytotoxic activity. , 1992, Journal of immunology.

[6]  D. Volsky,et al.  Uniform detection of HIV‐1 in alveolar macrophages of pediatric but not adult AIDS patients , 1993, Journal of leukocyte biology.

[7]  W. Farrar,et al.  Cytokine regulation of human immunodeficiency virus expression. , 1991, Cytokine.

[8]  A. Fauci,et al.  Interleukin 1 induces expression of the human immunodeficiency virus alone and in synergy with interleukin 6 in chronically infected U1 cells: inhibition of inductive effects by the interleukin 1 receptor antagonist. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[9]  A. Fauci,et al.  The human immunodeficiency virus: infectivity and mechanisms of pathogenesis. , 1988, Science.

[10]  B. Autran,et al.  Evidence for a cytotoxic T-lymphocyte alveolitis in human immunodeficiency virus-infected patients. , 1988, AIDS.

[11]  Human T lymphotropic virus type III infection of human alveolar macrophages. , 1986 .

[12]  R. Lockey,et al.  Elevated serum levels of IL‐8 in patients with HIV infection , 1993, Clinical and experimental immunology.

[13]  H. Masur,et al.  Impaired production of lymphokines and immune (gamma) interferon in the acquired immunodeficiency syndrome. , 1984, The New England journal of medicine.

[14]  M. Clerici,et al.  Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical staging. , 1989, The Journal of clinical investigation.

[15]  S. Garbisa,et al.  Release of granulocyte-macrophage colony-stimulating factor by alveolar macrophages in the lung of HIV-1-infected patients. A mechanism accounting for macrophage and neutrophil accumulation. , 1992, Journal of immunology.

[16]  B. Autran,et al.  Human immunodeficiency virus-related lymphocytic alveolitis. , 1988, Chest.

[17]  E. Unanue,et al.  Interleukin 12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[18]  G. Kaplan,et al.  Thalidomide inhibits the replication of human immunodeficiency virus type 1. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[19]  R. Redfield,et al.  Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections. , 1986, MMWR. Morbidity and mortality weekly report.

[20]  F. Ognibene,et al.  Leukotriene B4 and interleukin-8 in human immunodeficiency virus-related pulmonary disease. , 1993, Chest.

[21]  T. Matsuyama,et al.  Cytokines and HIV infection: is AIDS a tumor necrosis factor disease? , 1991, AIDS.

[22]  D. Mitchell,et al.  Alveolar macrophages in AIDS patients: increased spontaneous tumour necrosis factor‐alpha production in Pneumocystis carinii pneumonia , 1990, Clinical and experimental immunology.

[23]  J. Berzofsky,et al.  Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus. , 1994, The Journal of clinical investigation.

[24]  M. Peuchmaur,et al.  In vivo production of interleukin‐10 by malignant cells in AIDS lymphomas , 1992, European journal of immunology.

[25]  T. Standiford,et al.  Interleukin-8 (IL-8): the major neutrophil chemotactic factor in the lung. , 1991, Experimental lung research.

[26]  J. Berzofsky,et al.  Role of T‐Cell Derived Cytokines in the Downregulation of Immune Responses in Parasitic and Retroviral Infection , 1992, Immunological reviews.

[27]  E. Coligan.  Current protocols in immunology , 1991 .

[28]  R. Winchester,et al.  Tissue infiltration in a CD8 lymphocytosis syndrome associated with human immunodeficiency virus-1 infection has the phenotypic appearance of an antigenically driven response. , 1993, The Journal of clinical investigation.

[29]  B. Dewald,et al.  A novel neutrophil-activating factor produced by human mononuclear phagocytes , 1988, The Journal of experimental medicine.

[30]  M. Clerici,et al.  T helper cell immune dysfunction in asymptomatic, HIV-1-seropositive individuals: the role of TH1-TH2 cross-regulation. , 1992, Chemical immunology.

[31]  J. Andrieu,et al.  Tumor necrosis factor production in HIV-seropositive subjects. Relationship with lung opportunistic infections and HIV expression in alveolar macrophages. , 1991, Journal of immunology.

[32]  D. Venzon,et al.  Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals. , 1993, The Journal of clinical investigation.

[33]  J. Berzofsky,et al.  Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro. , 1993, Science.

[34]  Giorgio,et al.  Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells , 1992, The Journal of experimental medicine.

[35]  M. Denis,et al.  A study of monokine release and natural killer activity in the bronchoalveolar lavage of subjects with farmer's lung. , 1993, The American review of respiratory disease.